IL17A and systemic lupus erythematosus: With the intervention of anti-B2285 Abs, the significant reductions in Th1 cells (CD4+ IFN-γ+) and Th17 cells (CD4+ IL-17+) were observed in B2285 group compared with those in SLE and KLH groups (all P<0.05).